Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap Up - Here's Why

Key Points

• Bio-Rad Laboratories (NYSE:BIO.B) shares experienced a significant increase, opening at $283.85 after closing at $247.05.
• The company reported a quarterly earnings per share (EPS) of $2.61, with a net margin of 12.50% and a return on equity of 4.01%.
• Bio-Rad has a market capitalization of $7.75 billion and maintains a low debt-to-equity ratio of 0.17, indicating strong financial health.

Bio-Rad Laboratories, Inc. (NYSE:BIO.B - Get Free Report) shares gapped up prior to trading on Friday . The stock had previously closed at $247.05, but opened at $283.85. Bio-Rad Laboratories shares last traded at $284.88, with a volume of 345 shares trading hands.

Bio-Rad Laboratories Price Performance

The firm has a 50 day simple moving average of $251.93 and a 200-day simple moving average of $248.55. The company has a quick ratio of 3.67, a current ratio of 5.12 and a debt-to-equity ratio of 0.17. The company has a market cap of $7.75 billion, a PE ratio of 24.29 and a beta of 0.78.

Bio-Rad Laboratories (NYSE:BIO.B - Get Free Report) last posted its earnings results on Thursday, July 31st. The company reported $2.61 earnings per share (EPS) for the quarter. Bio-Rad Laboratories had a return on equity of 4.01% and a net margin of 12.50%.

About Bio-Rad Laboratories

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.